T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

ABSTRACT:

SUBMITTER: Pothast CR 

PROVIDER: S-EPMC12580724 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature